ArticleFrontiers in pharmacology2025
Community pharmacists' views towards implementing a patient self-administered screening tool designed to identify risk of medication-related problems.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: There is limited information regarding community pharmacists' perspectives on implementing a self-administered screening tool for identifying patients at risk of medication-related problems. This study assessed Australian pharmacists' views on introducing such a tool within the community pharmacy setting. Methods: An online cross-sectional survey was conducted among Australian community pharmacists from March to May 2023. The survey collected relevant demographic data and responses on perceived barriers and facilitators to implementing the screening tool. Reliability statistics were computed for the responses on barriers and facilitators, and chi-square or Fisher's Exact tests were performed to assess their association with demographic variables. Results: Two hundred thirty-one community pharmacists across Australia were surveyed. Most (78%) reported that medication-related problems are common and expressed support for a patient self-administered screening tool to identify patients at high risk of medication-related problems (88%). Over two-thirds (69%) were willing to allocate time for reviewing patient medications if flagged for medication-related problems. The most frequently anticipated barriers to implementing screening tools were time constraints for pharmacists (63%), staff shortage and limited patient interest (each accounting for 57%). In contrast, effective communication with patients (69%) and patients' appreciation of pharmacists' expertise and efforts (67%) were predominantly stated facilitators. Conclusion: Most community pharmacists were supportive of implementing a patient self-administered screening tool to identify patients at risk of medication-related problems. The study's findings provide valuable insights for developing medication-related problems screening tools tailored to the Australian community pharmacy setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.